Skip to content

Laboratoire DIPO: what changed

What changed

Laboratoire DIPO

BE 0887.494.966
NACE 20.420, Manufacture of chemicals and chemical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€774
2024 · €20+€754
Equity
€23,847
2024 · €23,073+€774
Cash
€176
2024 · €19+€158
Balance sheet total
€24,259
2024 · €23,487+€772

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€614

    up €614 (+2.6%), from €23,468 to €24,082

    of which Other amounts receivable: +€824

Equity and liabilities
  • Profit (loss) carried forward +€774

    up €774 (+11.2%), from -€6,927 to -€6,153

  • Other debts -€414

    no longer reported in 2025 (was €414)

  • Tax, wage and social debts +€412

    new in 2025: €412

Income statement
  • Gross operating margin +€826

    up €826 (+476%), from €174 to €1,000

  • Financial charges +€73

    up €73 (+47.3%), from €154 to €226

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €20
Gross operating margin +€826
Financial charges -€73
Result 2025 €774
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€158
Investment €0
Financing €0
Cash 2024 €19
Net result for the year +€774
Receivables within one year -€614
Tax, wage and social debts +€412
Other debts -€414
Cash 2025 €176
brings cash intakes cash out
Every line side by side 22 lines
Line Code 2024 2025 Change %
Total assets 20/58 €23,487 €24,259 +€772 +3.3%
Current assets 29/58 €23,487 €24,259 +€772 +3.3%
Amounts receivable within one year 40/41 €23,468 €24,082 +€614 +2.6%
Trade receivables 40 €21,926 €21,716 -€210 -1.0%
Other amounts receivable 41 €1,542 €2,366 +€824 +53.4%
Cash at bank and in hand 54/58 €19 €176 +€158 +852%
Total equity and liabilities 10/49 €23,487 €24,259 +€772 +3.3%
Equity 10/15 €23,073 €23,847 +€774 +3.4%
Contributions 10/11 €30,000 €30,000 = 0.0%
Profit (loss) carried forward 14 -€6,927 -€6,153 +€774 +11.2%
Amounts payable 17/49 €414 €412 -€2 -0.4%
Amounts payable within one year 42/48 €414 €412 -€2 -0.4%
Taxes, remuneration and social security 45 - €412 +€412
Taxes 450/3 - €412 +€412
Other amounts payable 47/48 €414 - -€414
Gross operating margin 9900 €174 €1,000 +€826 +476%
Operating profit (loss) 9901 €174 €1,000 +€826 +476%
Financial charges 65/66B €154 €226 +€73 +47.3%
Recurring financial charges 65 €154 €226 +€73 +47.3%
Profit (loss) for the period before taxes 9903 €20 €774 +€754 +3,784%
Profit (loss) for the period 9904 €20 €774 +€754 +3,784%
Profit (loss) for the period to be appropriated 9905 €20 €774 +€754 +3,784%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.